The record → All 128 providers → bmiMD
Provider Dossier · bmimd.com · Last verified 16 November 2026
Is bmiMD legit?
Quick answerLast verified · GLP-1 Dossier Editorial Desk
Our enforcement sweep matched 1 primary-sourced regulatory or legal action on file involving bmiMD (bmimd.com), each linked to the original document below.
Published prices start at $99/mo, with medication included.
It supplies compounded GLP-1 medication, which is not FDA-approved.
Disclosure: Affiliate link (bmiMD pays a referral commission at no extra cost to you).
Yes, bmiMD (bmimd.com) is a real, operating US telehealth company that ships prescriptions, not a counterfeit card-skimming site. However, our enforcement sweep matched 1 primary-sourced regulatory or legal action on file involving the company, each linked to the original government or court document below.
On the clinical side, bmiMD prescribes compounded GLP-1 medication only (prepared by a compounding pharmacy rather than an FDA-approved manufacturer), and its published plan starts at $99/mo (medication included).
Comparing bmiMD against compounded only providers with 0 actions on file
bmiMD has 1 regulatory or legal action documented below. For readers comparing transparent options in the same supply category before entering payment details, these providers have 0 actions on file and published monthly pricing:
- Website & Terms inspected
- bmimd.com (Direct checkout & Terms of Service verified)
- Last price & terms read
- 16 November 2026 (Medication included in quoted monthly rate · Flat rate across all doses)
- 503A / 503B pharmacy disclosure
- No partner compounding pharmacy named upfront before intake
- Public registries searched
- FDA CDER Warning Letters (2024–2026), Federal District Court Dockets (PACER / CourtListener), FTC Enforcement Actions, NAD Case Reports → 1 primary document linked below
- Researcher field note
- Operated by Medccm, Inc. (420 Lexington Ave, Suite 1402, New York, NY 10170). Sells compounded semaglutide and tirzepatide (including microdose plans) at flat dosing rates across all 50 states, with full refund if a clinician determines you are ineligible, a $50 administrative cancellation fee if you cancel after intake review begins, and a strict non-refundable rule on prepaid multi-month plans once the first shipment is sent to the pharmacy. Auto-renewal holds are placed five days before renewal and cancellation requires at least seven days' notice before the renewal date. Neither the medical group nor the dispensing compounding pharmacies are named on the public site prior to enrollment.
What it actually supplies
Supplies compounded semaglutide or tirzepatide: medication prepared by a compounding pharmacy rather than an FDA-approved product. Cheaper, legal, and the category the FDA has been issuing warning letters about since September 2025.
Named on its own site (bmimd.com): Compounded semaglutide, Compounded tirzepatide, Compounded semaglutide microdose, Compounded tirzepatide microdose.
What regulators and courts have said
Every entry below links to its original document and identifies the source type. We publish what the official record states and nothing beyond it; a regulatory letter or lawsuit involving a company is not proof that an individual patient was harmed.
May 2025
Novo Nordisk A/S and Novo Nordisk Inc. sued MEDCCM, Inc. (the corporate operator of bmiMD) in the Eastern District of New York on 21 May 2025 (No. 2:25-cv-02846), asserting Lanham Act trademark infringement claims over its marketing of compounded GLP-1 products. As of mid-2026 the case remained pending before Judge Joan M. Azrack following briefing on MEDCCM's motion to dismiss; allegations unproven.
Other signals on file
Not regulatory or legal actions, and never counted as such. We log these items separately because they are sourced and relevant to prospective patients (complaint volumes, corporate and pharmacy disclosures, third-party lab reports, or commercial disputes).
January 2026
Better Business Bureau profile for bmiMD (Medccm, Inc., New York, NY) carries an F rating, citing failure to respond to customer complaints regarding subscription renewals, cancellation holds and Groupon voucher redemptions.
Corporate entity, pricing & cancellation terms
Operated by Medccm, Inc. (420 Lexington Ave, Suite 1402, New York, NY 10170). Sells compounded semaglutide and tirzepatide (including microdose plans) at flat dosing rates across all 50 states, with full refund if a clinician determines you are ineligible, a $50 administrative cancellation fee if you cancel after intake review begins, and a strict non-refundable rule on prepaid multi-month plans once the first shipment is sent to the pharmacy. Auto-renewal holds are placed five days before renewal and cancellation requires at least seven days' notice before the renewal date. Neither the medical group nor the dispensing compounding pharmacies are named on the public site prior to enrollment.
Go direct
The button below is an affiliate link: if you sign up, bmiMD pays us a referral commission and your price does not change. That relationship has not altered a word of this dossier, and every regulatory action above links to the primary government or court document so you can check our work directly.
Visit bmiMD (bmimd.com) →Lower advertised starting prices
Providers advertising a lower monthly entry figure. Check each dossier before comparing two numbers: the headline price alone does not tell you whether medication is included.
If you prefer FDA-approved medication only
These clinics prescribe FDA-approved brand-name drugs only and currently have 0 regulatory actions on file here.
Side-by-side records
Compared with the alternatives
Direct dossier comparisons for the providers patients most frequently weigh against bmiMD.
Long-form provider files
Full price tables, terms and records
Every plan length, the refund and cancellation terms, named pharmacies, review-site links and each regulatory action with its primary document. These 6 providers pay us a referral commission if you sign up through our links; ordered by lowest verified monthly price only.
| Provider file | Sema. /mo | Tirz. /mo | Actions on file | Links |
|---|---|---|---|---|
| Embody | $49 | $99 | None | Read the dossier →Embody site ↗ |
| Belle | $93 | $149 | 1 | Read the dossier →Belle site ↗ |
| PlexusDx | $99 | $129 | None | Read the dossier →PlexusDx site ↗ |
| MEDGm | $169 | $269 | None | Read the dossier →MEDGm site ↗ |
| DirectMeds | $249 | $399 | 1 | Read the dossier →DirectMeds site ↗ |
| GoodLife Health | $299 membership | + brand-name drug | None | Read the dossier →GoodLife Health site ↗ |
- Embodyfrom $49/moSema. $49 · Tirz. $99None on file
- Bellefrom $93/moSema. $93 · Tirz. $1491 on file
- PlexusDxfrom $99/moSema. $99 · Tirz. $129None on file
- MEDGmfrom $169/moSema. $169 · Tirz. $269None on file
- DirectMedsfrom $249/moSema. $249 · Tirz. $3991 on file
- GoodLife Healthfrom $299/mo + drugMembership; brand-name drug billed separatelyNone on file
Each row has two links: “Read the dossier” opens our file on that provider, and the “site ↗” button opens the provider’s own site in a new tab. Nothing else in the row is a link. Where a provider runs an affiliate programme with us, its site button is a referral link and we may earn a commission at no cost to you. It never changes the order or what is on file.
Reference notes
bmiMD: key questions answered
- Is bmiMD (bmimd.com) legit or a scam? What does the public record show?
- Yes. bmiMD (bmimd.com) is an active, operating US weight-loss telehealth company. It supplies compounded semaglutide or tirzepatide prepared by a state-licensed compounding pharmacy rather than an FDA-approved brand-name drug. Our regulatory sweep matched 1 primary-sourced regulatory or legal action on file: Novo Nordisk A/S and Novo Nordisk Inc. sued MEDCCM, Inc. (the corporate operator of bmiMD) in the Eastern District of New York on 21 May 2025 (No. 2:25-cv-02846), asserting Lanham Act trademark infringement claims over its marketing of compounded GLP-1 products. As of mid-2026 the case remained pending before Judge Joan M. Azrack following briefing on MEDCCM's motion to dismiss; allegations unproven.
- Does bmiMD sell compounded or FDA-approved weight loss medication?
- Compounded only. Supplies compounded semaglutide or tirzepatide: medication prepared by a compounding pharmacy rather than an FDA-approved product. Cheaper, legal, and the category the FDA has been issuing warning letters about since September 2025. Specifically named on bmimd.com: Compounded semaglutide, Compounded tirzepatide, Compounded semaglutide microdose, Compounded tirzepatide microdose.
- What are bmiMD weight loss pricing, hidden fees, and cancellation terms?
- bmiMD (bmimd.com) publishes weight-loss plans starting at $99 per month, with medication included in that monthly figure. Contract and billing terms: No separate membership fee; on 12 Nov 2026, during an “Early Black Friday” sale (limited time, no end date shown), bmimd.com/compounded-semaglutide listed compounded semaglutide at $99/mo on a 12-month plan ($1,188 total), $109/mo on 6 months ($654), $119/mo on 3 months ($357) or $129/mo month to month, each against a $229/mo list price; bmimd.com/compounded-tirzepatide listed compounded tirzepatide at $139/mo on 12 months ($1,668), $149/mo on 6 months, $159/mo on 3 months or $179/mo month to month, against a $349/mo list price. Operated by Medccm, Inc. (420 Lexington Ave, Suite 1402, New York, NY 10170). Sells compounded semaglutide and tirzepatide (including microdose plans) at flat dosing rates across all 50 states, with full refund if a clinician determines you are ineligible, a $50 administrative cancellation fee if you cancel after intake review begins, and a strict non-refundable rule on prepaid multi-month plans once the first shipment is sent to the pharmacy. Auto-renewal holds are placed five days before renewal and cancellation requires at least seven days' notice before the renewal date. Neither the medical group nor the dispensing compounding pharmacies are named on the public site prior to enrollment.
- What compounding or fulfillment pharmacy does bmiMD use?
- bmiMD (bmimd.com) states that compounded GLP-1 prescriptions are fulfilled through state-licensed 503A or 503B compounding pharmacies, without listing specific partner pharmacy names on its public pre-checkout pages. Patients can verify the exact compounding pharmacy, address, and state board license number printed on the prescription vial label upon delivery.
- Are there FDA warning letters, lawsuits, or regulatory complaints against bmiMD?
- Yes. We hold 1 primary-sourced regulatory or legal action on record involving bmiMD (bmimd.com): Novo Nordisk A/S and Novo Nordisk Inc. sued MEDCCM, Inc. (the corporate operator of bmiMD) in the Eastern District of New York on 21 May 2025 (No. 2:25-cv-02846), asserting Lanham Act trademark infringement claims over its marketing of compounded GLP-1 products. As of mid-2026 the case remained pending before Judge Joan M. Azrack following briefing on MEDCCM's motion to dismiss; allegations unproven. Every entry links directly to the primary FDA, NAD, or court document on this page. Separately from regulatory enforcement, our file notes 1 other sourced signal: Better Business Bureau profile for bmiMD (Medccm, Inc., New York, NY) carries an F rating, citing failure to respond to customer complaints regarding subscription renewals, cancellation holds and Groupon voucher redemptions.